Pharmafile Logo

Apodi Ltd

Established in 2006 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to pharmaceutical and healthcare businesses and organisations. We recognise that the business environment for these industry sectors is changing and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI. Through commercial insight, market intelligence and highly motivated people, Apodi helps our clients achieve improved outcomes and performance. Over the years we have worked hard to break the traditional model with a focus on the changing NHS environment and the challenge we all face to improve patient outcomes.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

One St Peters Road, Maidenhead, Berks, SL6 7QU, United Kingdom
+44 (0)1628 500 890

 Latest Content from PMHub 

Advance Outcomes named of the most innovative strategies of 2020 by PM360

PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Lucid Group’s pioneering behaviour-change methodology, Advance OutcomesTM, as one of...

Lucid Group Evolve and Simplify its Brand Architecture

The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise...

University spin-out fund makes half a million pound first investments

Press Releases | December 8, 2020 | Onyx Health

University partnership Northern Accelerator has made over £500,000 worth of investments into two innovative university spin-out businesses in the health and biotech sectors from its £1.7M Seed Investment Fund

Migraine-friendly colours for the home

Press Releases | December 4, 2020 | 11 London

You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1,200 migraine...

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Not waving but drowning. Reflections on data curation in the age of information overload

As of October 2019 there were over 300,000 clinical studies registered worldwide, compared to just over 2,100 in the year 2000’It’s common to hear colleagues and friends bemoan the huge...

The patient journey: A long and winding road

Reflections of a research executive

Webcast

White Papers and Resources | November 30, 2020 | Inizio

The power of a good story: Turn your insights into effective storytelling with data visualisation